Search results for: Innovation Policy Prize

OHE Lunchtime Seminar on 6 October 2015 PharmaDiplomacy: A Proposal for a Collaborative, Mutually Acceptable Approach to Drug Pricing

22 September 2015

On Tuesday 6th October, James Anderson (GSK), Ri De Ridder (RIZIV-INAMI), and Sophia Tickell (Meteosan) will take part in an OHE seminar to discuss the Checklist for Collaborative, Mutually Acceptable…

Newly Published Analysis: Dementia: the R&D Landscape

16 November 2015

Just published by the World Dementia Council and OHE is an analysis which sets out the dementia R&D landscape. This analysis was undertaken by OHE for Imperial College and the…

How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards

24 November 2015

A new OHE Consulting Report assesses information governance arrangements for real-world data in eight countries, and makes recommendations towards an ideal governance framework. Real world data (RWD) is a term…

Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?

29 February 2016

…contact Martina Garau at OHE. Related work: Johannesson, M., Jonsson, B., Jonsson, L., Kobelt, G. and Zethraeus, N., 2009. Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?…

OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples

29 March 2016

…one hand, by the pharmaceutical industry and by patient groups for being too cautious in its approach to appraising medical innovation, and, on the other hand, by NHS managers and…

New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions

10 May 2016

…an intervention to offset the projected increase in DALY burden of dementia in the UK by 2025 appears low”. Dr Matthew Norton, Head of Policy at Alzheimer’s Research UK, said:…

OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?

17 May 2016

…Technology Assessment in Health Care, 31(6), pp.449-456. Johannesson, M., Jonsson, B., Jonsson, L., Kobelt, G. and Zethraeus, N., 2009. Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective? …

What Drives Variations in Relative Effectiveness Across Countries?

31 May 2016

…between populations and healthcare systems. Relative effectiveness is a key topic within health policy. In Europe, this is due to the need for early information to guide reimbursement and funding…

Presentation at the NHS Global Health Volunteering Group Meeting: “The Value of International Volunteering and Placements to the NHS”

…economic value for the NHS from international volunteering is mainly derived from diffusion of innovation in management and service delivery. The private value for the volunteers comes from increased productivity…